Filing Details
- Accession Number:
- 0001140361-13-017207
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-23 17:16:31
- Reporting Period:
- 2013-04-19
- Filing Date:
- 2013-04-23
- Accepted Time:
- 2013-04-23 17:16:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557533 | Robert Jeffrey Ajer | C/O Biomarin Pharmaceutical Inc., 105 Digital Drive Novato CA 94949 | Svp, Chief Commercial Of | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-04-19 | 5,000 | $21.51 | 15,570 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-04-19 | 5,000 | $65.00 | 10,570 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) Common Stock | Disposition | 2013-04-19 | 5,000 | $0.00 | 5,000 | $21.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,500 | 2010-11-12 | 2020-05-11 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 plan executed on December 11, 2012.
- Original option grant vests 6/48th on November 12, 2010 and 1/48th on the 12th of each month thereafter.
- Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.
Billionaire Hedge Funds
